Enhanced Cellular Doxorubicin Uptake via Delayed Exposure Following Nanosecond Pulsed Electric Field Treatment: An In Vitro Study

Rongwei Ma,Yubo Wang,Zhihao Wang,Shengyong Yin,Zhen Liu,Keping Yan

DOI: https://doi.org/10.3390/pharmaceutics16070851

IF: 6.525

2024-06-25

Pharmaceutics

Abstract:The combination of nanosecond Pulsed Electric Field (nsPEF) with pharmaceuticals is a pioneering therapeutic method capable of enhancing drug uptake efficacy in cells. Utilizing nsPEFs configured at 400 pulses, an electric field strength of 15 kV/cm, a pulse duration of 100 ns, and a repetition rate of 10 pulses per second (PPS), we combined the nsPEF with a low dose of doxorubicin (DOX) at 0.5 μM. Upon verifying that cells could continuously internalize DOX from the surrounding medium within 1 h post nsPEF exposure, we set the DOX exposure period to 10 min and contrasted the outcomes of varying sequences of DOX and nsPEF administration: pulsing followed by DOX, DOX followed by pulsing, and DOX applied 40 min after pulsing. Flow cytometry, CCK-8 assays, and transmission electron microscopy (TEM) were employed to examine intracellular DOX accumulation, cell viability, apoptosis, cell cycle, and ultrastructural transformations. Our findings demonstrate that exposing cells to DOX 40 min subsequent to nsPEF treatment can effectively elevate intracellular DOX levels, decrease cell viability, and inhibit the cell cycle. This research work presents a novel approach to enhance DOX uptake efficiency with moderate conditions of both DOX and nsPEF.

pharmacology & pharmacy

What problem does this paper attempt to address?

The problem that this paper attempts to solve is how to improve the uptake efficiency of doxorubicin (DOX) by cancer cells through optimizing the combined use method of nanosecond - pulsed electric field (nsPEF) and the chemotherapeutic drug doxorubicin (DOX), thereby enhancing the treatment effect and reducing drug side effects at the same time. Specifically, the researchers explored the effects of administering DOX at different time points (i.e., immediately before or after nsPEF treatment, or 40 minutes after nsPEF treatment) on intracellular DOX concentration, cell survival rate, apoptosis, cell cycle, and ultrastructural changes of cells.

Through this series of experiments, the researchers hope to find an effective method to increase the accumulation of the drug in target cells through nsPEF technology on the premise of ensuring the use of low - dose DOX, thereby improving the safety and efficacy of anticancer treatment. The paper mentions that traditional use of DOX may increase oxidative stress and lead to problems such as cardiotoxicity. Therefore, it is very necessary to find an efficient release method to enhance the uptake of low - concentration DOX by local cells. This study proposes a novel method, that is, administering DOX 40 minutes after nsPEF treatment can effectively increase the intracellular DOX level, reduce the cell survival rate, and inhibit the cell cycle, providing a solution under mild conditions for improving the DOX uptake efficiency.